A recent analysis of inflammatory markers in MDD patients using a cytokine panel has confirmed the elevation of pro-inflammatory interleukins and highlighted abnormalities in additional factors, such as MIP-1 and eotaxin, not previously implicated in MDD [6]. The gene discussed is CCL11; the disease is major depressive disorder.